COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect

Editorial Material Clinical Neurology

COVID-19 vaccine and Guillain-Barre syndrome: let's not leap to associations

Michael P. Lunn et al.

BRAIN (2021)

Article Biochemistry & Molecular Biology

Looking beyond COVID-19 vaccine phase 3 trials

Jerome H. Kim et al.

Summary: Following the announcement of COVID-19 vaccine efficacy in clinical trials, a comprehensive strategy is needed for global vaccination, including manufacturing, support, supply coordination, equitable distribution, and logistics. Additionally, addressing scientific questions to improve vaccine efficacy is crucial for ending the pandemic effectively and efficiently.

NATURE MEDICINE (2021)

Add to Collection

Editorial Material Clinical Neurology

ANA Investigates: Neurological Complications of COVID-19 Vaccines

Adeline L. Goss et al.

ANNALS OF NEUROLOGY (2021)

Add to Collection

Letter Clinical Neurology

Neurological side effects of COVID-19 vaccines are rare

Lu Lu et al.

ACTA NEUROLOGICA SCANDINAVICA (2021)

Add to Collection

Article Infectious Diseases

Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers

Renuka A. K. Kadali et al.

Summary: A study on the side effects of the BNT162b2 mRNA vaccine for COVID-19 among healthcare workers revealed that most of the vaccinated individuals experienced some symptoms post vaccination, but the majority still intended to receive the second dose.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Chemistry, Medicinal

COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

Zhi-Peng Yan et al.

Summary: Various strategies, including vaccine development, have been designed to contain the COVID-19 pandemic. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile, and usage in various populations, highlighting the importance of comparing protective efficacy and risks of vaccination for global control through herd immunity.

PHARMACEUTICALS (2021)

Add to Collection

Editorial Material Virology